Philogen S.p.A.
Status: Publicly traded
Direct answer
Philogen S.p.A. is publicly traded on MIL under the ticker PHIL.MI.
Philogen S.p.A. is a biotechnology firm dedicated to creating therapeutic agents for cancer and persistent inflammatory conditions. Among its pipeline, Nidlegy is being developed as an intralesional therapy for localized melanoma and non-melanoma skin cancers, combining the immunocytokines L19IL2 and L19TNF. Another key product is Fibromun, a human immunomodulatory agent composed of the L19 antibody and TNF, aimed...
Can you invest in Philogen S.p.A.?
Yes. Philogen S.p.A. trades publicly on MIL as PHIL.MI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Philogen S.p.A.
Detailed equity research is provided by MarketSnap.